Neoral reduces the incidence of acute rejection after renal transplantation.
Sandrini
S
S
Institute of Nephrology, University and Spedali Civili, Brescia, Italy.
Setti
G
G
Gaggia
P
P
Chiappini
R
R
Maffeis
R
R
Tardanico
R
R
Maiorca
R
R
D000284:Administration, Oral; D016572:Cyclosporine / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control*; D006085:Graft Survival; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D015994:Incidence; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D008297:Male; D012189:Retrospective Studies; D015996:Survival Rate
D007166:Immunosuppressive Agents; D016572:Cyclosporine